These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 30709850)
21. Establishment of de novo DNA methylation patterns. Transcription factor binding and deoxycytidine methylation at CpG and non-CpG sequences in an integrated adenovirus promoter. Toth M; Müller U; Doerfler W J Mol Biol; 1990 Aug; 214(3):673-83. PubMed ID: 2143784 [TBL] [Abstract][Full Text] [Related]
22. A consensus DNA recognition motif for two KDWK transcription factors identifies flexible-length, CpG-methylation sensitive cognate binding sites in the majority of human promoters. Burnett E; Christensen J; Tattersall P J Mol Biol; 2001 Dec; 314(5):1029-39. PubMed ID: 11743720 [TBL] [Abstract][Full Text] [Related]
23. Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter. Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ Mol Carcinog; 2016 Dec; 55(12):1940-1951. PubMed ID: 26676339 [TBL] [Abstract][Full Text] [Related]
24. Paradox of sonic hedgehog (SHH) transcriptional regulation: Alternative transcription initiation overrides the effect of downstream promoter DNA methylation. ten Haaf A; Franken L; Heymann C; von Serenyi S; Cornelissen C; de Hoon JP; Veeck J; Lüscher B; Knüchel R; Dahl E Epigenetics; 2011 Apr; 6(4):465-77. PubMed ID: 21372638 [TBL] [Abstract][Full Text] [Related]
25. CpG methylation at the USF-binding site is important for the liver-specific transcription of the chipmunk HP-27 gene. Fujii G; Nakamura Y; Tsukamoto D; Ito M; Shiba T; Takamatsu N Biochem J; 2006 Apr; 395(1):203-9. PubMed ID: 16396632 [TBL] [Abstract][Full Text] [Related]
26. Characterization of the NLRC5 promoter in chicken: SNPs, regulatory elements and CpG islands. Guo XM; Liu XP; Chang GB; Xu L; Bi YL; Wang HZ; Zhang Y; Zhu PF; Wu Y; Chen GH Anim Genet; 2016 Oct; 47(5):579-87. PubMed ID: 27429394 [TBL] [Abstract][Full Text] [Related]
27. Polycomb-like proteins link the PRC2 complex to CpG islands. Li H; Liefke R; Jiang J; Kurland JV; Tian W; Deng P; Zhang W; He Q; Patel DJ; Bulyk ML; Shi Y; Wang Z Nature; 2017 Sep; 549(7671):287-291. PubMed ID: 28869966 [TBL] [Abstract][Full Text] [Related]
28. Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3. Archey WB; Sweet MP; Alig GC; Arrick BA Cancer Res; 1999 May; 59(10):2292-6. PubMed ID: 10344731 [TBL] [Abstract][Full Text] [Related]
29. Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts. Villagra A; Gutiérrez J; Paredes R; Sierra J; Puchi M; Imschenetzky M; Wijnen Av Av; Lian J; Stein G; Stein J; Montecino M J Cell Biochem; 2002; 85(1):112-22. PubMed ID: 11891855 [TBL] [Abstract][Full Text] [Related]
30. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nguyen CT; Gonzales FA; Jones PA Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309 [TBL] [Abstract][Full Text] [Related]
31. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126 [TBL] [Abstract][Full Text] [Related]
32. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients. Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586 [TBL] [Abstract][Full Text] [Related]
33. Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. Woodcock DM; Lawler CB; Linsenmeyer ME; Doherty JP; Warren WD J Biol Chem; 1997 Mar; 272(12):7810-6. PubMed ID: 9065445 [TBL] [Abstract][Full Text] [Related]
34. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141 [TBL] [Abstract][Full Text] [Related]
35. CpG island methylation status in the EpCAM promoter region and gene expression. Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402 [TBL] [Abstract][Full Text] [Related]
36. Site-specific methylation of the promoter alters deoxyribonucleic acid-protein interactions and prevents follicle-stimulating hormone receptor gene transcription. Griswold MD; Kim JS Biol Reprod; 2001 Feb; 64(2):602-10. PubMed ID: 11159363 [TBL] [Abstract][Full Text] [Related]
38. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2). Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525 [TBL] [Abstract][Full Text] [Related]
39. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer. Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931 [TBL] [Abstract][Full Text] [Related]
40. CpG traffic lights are markers of regulatory regions in human genome. Lioznova AV; Khamis AM; Artemov AV; Besedina E; Ramensky V; Bajic VB; Kulakovskiy IV; Medvedeva YA BMC Genomics; 2019 Feb; 20(1):102. PubMed ID: 30709331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]